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MicroRNA
 small, non-protein-coding RNA molecules~ 22 nucleotides(1)
 regulate gene expression by inhibiting translation and/or by 
inducing degradation of target mRNAs(2)
 Repress activity of complementary mRNAs(1)
 1 miRNA = hundreds of mRNAs (1)
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MicroRNA
 The human genome may encode over 1000 miRNAs (1) 
 Regulate 60% of mammalian gene products(1) 
 They have been identified to play a key role in organ development, 
cellular differentiation, proliferation and function(1)
 Have been described in invertebrates and vertebrates: worms, 
fungi, plants, and mammals(1)
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History of miRs
 In 1987,Fergunsson et al, found that lin-4 could negatively 
regulate lin-14(3)
 In 1989, Ambros focus his research on lin-4 gene and 
Ruvkun on the study lin-14 gene.(4)
 In 1992 Ambros and  Ruvkun : lin-4 transcripts were 
complementary to a repeated sequence in the 3´UTR of lin-
14 gene. (5)
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History of miRs
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Mack GS. Nature biotechnology. 2007;25(6):631-8.
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Function of miRs
Named miRs
 hsa-miR-100 Homo sapiens
 dme-miR-100 Drosophila melanogaster
 miR-15-5p
 miR-15-3p*
 miR-181a 
 miR-181b(6)
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Relevance 
of miRs to 
Human 
Biology
in Cancer
inCell Growth 
and Death
in 
cardiovascular 
diseases
in the nervous 
system
in autoimmune 
diseases
in stem cell 
research
in plasma or 
serum
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microRNAs in Cancer
 In 2002, the first report ,miR-15 , miR-16 were found to be located at 
chromosome 13q14, a region frequently deleted in CLL (7)
 In 2005, MicroRNAs can act as oncogenes or tumor suppressors(8)
 In 2006, Saito et al. controlled by : DNA methylation , histone 
modifications(9)
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miRNAs as Oncogenes and Tumor Supressors
Zhang et al Dev Biol. 2007 Feb 1;302(1):1-12
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Pichler M, Calin G.British journal of cancer. 2015;113(4):569-73.
microRNAs in Cancer
microRNAs in Cancer
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in 2015
Ferracin M et al
miR-181a-5p as a diagnostic 
breast cancer biomarker(10).
microRNAs in Cancer
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miRNAs Regulate Cell Growth and Death
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microRNAs in cardiovascular diseases
 In 2005, Zhao et al.miR-1-1,miR-1-2 were specifically expressed in
cardiac and skeletal muscle precursor cells(11).
 In 2006, Rooij et al. microarray analysis,more than 12 miRNAs were
cardiac hypertrophy and heart failure (12).
 In 2010,Edwards et al. several studies demonstrated miRNA aberrant
patterns in cardiac hypertrophy and analyzed their roles(13).
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microRNAs in cardiovascular diseases
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Romaine SP, Tomaszewski M, Condorelli G, Samani NJ.. 2015;101(12):921-8.
microRNAs in the nervous system
involving brain plasticity
neuronal cell maturation
 key regulators of CNS development
neuronal cell differentiation
synaptogenesis
 Dysregulation Alzheimer, Parkinson, Huntington (14)
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microRNAs in the nervous system
22Parvini N, Ahmadi S. The Neuroscience Journal of Shefaye Khatam. 2015;3(1):0
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microRNAs in autoimmune diseases
Pauley KM, Cha S, Chan EK. Journal of autoimmunity. 2009;32(3):189-94
24
microRNAs in autoimmune diseases
Deng X, Su Y, Wu H, Wu R, Zhang P, Dai Y, et al. Scandinavian journal of immunology. 2015;81(3):153-65.
microRNAs  in stem cell research
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Navarro A, Monzó M. Yonsei medical journal. 2010;51(5):622-32.
microRNAs  in stem cell research
In 2015 Zhou C et al
overexpression of pluripotency stem cell-specific miRNA-302/367 
cluster, miRNA-9/9 and miRNA-124 induced fibroblasts conversion 
into neurons.
important implications : studies of neuron development and 
neurological disease therapy.(15)
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microRNAs  in stem cell research
In 2015 Möbus S et al
miR-199a-5p inhibition in ES-derived HLCs leads to 
improved hepatocyte differentiation.
Upon transplantation, HLCs were able to engraft and 
repopulate the liver of mice.
miRNA modulation may serve as a promising approach 
to generate more mature HLCs from stem cell sources 
for the treatment of liver diseases.(16)27
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in 2008 first report 
Chim et al
miRNAs as diagnostic tools in 
biological fluids
detected placental miRNAs in the 
maternal plasma(17)
in 2008 Lawrie et al
comparing serum from diffuse large 
B-cell lymphoma patients and 
healthy controls
miR-155, miR-210 and miR-21 
levels were significantly upregulated
in patients(18)
microRNAs as biomarkers in plasma or serum
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in 2010 Murata et al
analyzed miRNAs plasma levels in 
rheumatoid arthritis
plasma miR-132 was significantly 
higher in healthy controls than in 
rheumatoid arthritis(19)
in 2015 Tsochandaridis et 
al
noninvasive diagnostic and
prognostic biomarkers for pregnancy 
monitoring
prevent the development of 
gestational disorders and form the 
basis of personalized therapeutic
strategies(20)
microRNAs as biomarkers in plasma or serum
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microRNA detection methods(21)
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Traditional 
methods
Northern 
blotting
RT-PCR
microarrays
microRNA detection methods
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New methods and 
developed 
nanoparticle-derived 
probes
isothermal 
amplification
electrochemical 
methods
Rolling cycle 
amplification
duplex specific 
nuclease 
nanotechnology and nanomaterials
 potent tools in bioanalysis
 detection of biological targets
 high sensitivity 
 high efficiency
gold nanoparticles
silver nanoculsters
Nanoparticles magnetic particles
quantum dots 
graphene oxide
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AuNPs-based methods
 Simple probe design,
 easy modification,
 biocompatibility,
 easy cellular-uptake
Disadvantages
Specialized nanotechnology platform needed
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Quantum dot-based methods
 Special fluorescence properties
 also easy modification
 simple design of probe
 easy cellular-uptake
Cell cytotoxicity
Disadvantages
unsuitable for multiple target detection
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Isothermal exponential amplification
No PCR needed
 good efficiency of signal amplification
 good sensitivity even low at the single cell level
 real-time assay in some cases
Complicated probe design
Disadvantages
multiple enzymes
35Presented by: Ghadimi
Under supervision: Dr. Ahmadpour
Some cleavage-based methods
 Simplified enzymatic system
 good sensitivity and selectivity
 less side reactions
Disadvantages                         Special enzymes needed
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Rolling cycle amplification
 no PCR needed,
 good efficiency of signal amplification 
 in situ detection achieved in some cases
Complicated probe design
nonspecific amplification
Disadvantages
background
more condition optimization needed
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DSN and AuNPs-based system
 0.2 fmol level detection
 simple design of probe 
Disadvantages Time consuming
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Capillary-electrophoresis-based assay
 Simple probe design
 multiple target detection 
Disadvantages
Specialized equipment need
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Using bioinformatics tools to identify miRs 
KEGG: http:// www.genome.jp/kegg/
Target Scan : http://www.targetscan.org/ 
miRBase: http://www.mirbase.org/ 
miRWalk: http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk
miRanda :http://www.microrna.org
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Using bioinformatics tools to identify miRs 
Diana-microT: http://diana.cslab.ece.ntua.gr/ 
TarBase: : http:// diana.cslab.ece.ntua.gr/
miRDB : http:// mirdb.org/
GEO: www.ncbi.nlm.nih.gov/gds
miRNAMap: http://mirnamap.mbc.nctu.edu.tw/
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